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The  efﬁcacy  of a novel  topical  combination  of  ﬁpronil  8.3%  (w/v),  (S)-methoprene  10%  (w/v),
eprinomectin  0.4%  (w/v) and  praziquantel  8.3%  (w/v)  (BROADLINE®) was  tested  against
adult and  immature  stages  of  Ctenocephalides  felis  ﬂeas  in  six studies.  For  that  purpose,  ﬂeas
from different  colonies  from  North  America,  Germany  and  South  Africa  were  used  to induce
infestations  in cats  under  laboratory  conditions.  In  each  study,  between  12  and 16  cats  were
allocated  randomly  to 2  groups.  Cats  in  Group  1  were  not  treated  and  served  as  controls.  Cats
in Group  2  were  treated  once  on Day  0 with  BROADLINE® at the  minimum  recommended
dosage  of 0.12 mg/kg  body  weight.  In  4  studies,  all  animals  were  infested  experimentally
with  unfed  C.  felis  (100  ± 5) on  Days  2 (or 1),  7, 14,  21,  28  and  35. Live  ﬂeas  were  counted  24 h
post-treatment  or infestation.  In 2 additional  studies,  animals  were  infested  at the same
frequency  with  gravid  C.  felis  ﬂeas  (100  ± 5) that  were  fed previously  on an  untreated  host.
Forty-eight  hours  post-infestation,  ﬂea  eggs  were  collected,  counted  and  incubated  for  the
evaluation  of the  reduction  of emergence  of adults.  The  combined  curative  efﬁcacy  against
adult ﬂeas  at  24  h after  treatment  was 94.3%  and  the combined  preventive  efﬁcacy  values
remained  greater  than  95.9%  at 24  h  after  5 subsequent  weekly  infestations.  In addition,
the  product  reduced  dramatically  the  emergence  of  new  adult  ﬂeas  for  at least  5 weeks
(>98.1%  for  one  month  and  93.2%  at  5  weeks  after  infestation),  demonstrating  its  efﬁciency
in  preventing  environmental  contamination  by  immature  stages.
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1. IntroductionThe cat ﬂea, Ctenocephalides felis, is the most com-
mon ectoparasite found on cats and many other animal
species worldwide (Rust and Dryden, 1997). In addition to
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ausing annoyance and discomfort to pets and their
wners, cat ﬂeas are associated with several diseases. C.
elis is primarily responsible for ﬂea bite allergy dermati-
is (FAD) in dogs and cats (Dryden and Blakemore, 1989;
lant, 1991; Carlotti and Costargent, 1994) as a result of
ypersensitivity to components of ﬂea saliva (Dryden and
ust, 1994; Stopler, 1994). The cat ﬂea is also the primary
ntermediate host of the tapeworm Dipylidium caninum, the
ommon intestinal cestode of dogs and cats (Dunn, 1978;
ugh, 1987). In addition, C. felis can transmit the agent of
ea-borne spotted fever, Rickettsia felis, and it has been
mplicated in the transmission of some Bartonella species,
uch as B. henselae, the agent of Cat Scratch Disease (Azad
t al., 1997; Orloski and Lathrop, 2003; Just et al., 2008;
ryden and Hodgkins, 2010).
Although the use of highly effective and practical insec-
icides such as ﬁpronil, imidacloprid or selamectin have
evolutionized ﬂea control, treatment and prevention of
at ﬂea infestations remain a major concern for pet owners
nd veterinarians (Rust, 2005; Dryden and Hodgkins, 2010;
eugnet and Franc, 2012; Siak and Burrows, 2013). The
ost difﬁcult component of ﬂea control is related to an
spect that the majority of pet owners are unaware of,
amely controlling the pre-existing environmental infes-
ation by immature stages (Rust, 2005; Beugnet and Franc
012; Beugnet and Fourie, 2013). As a result, pet owners
nly treat their animals once when they see ﬂeas, an
pproach that allows for continuous re-infestations by new
merging ﬂeas. In order to improve owner compliance,
here is a need for efﬁcient and easy to administrate solu-
ions allowing integrated control.
Broadline® (Merial) is a new topical combination of
pronil, (S)-methoprene, eprinomectin and praziquantel
eveloped for cats with the aim to offer a wide spectrum of
ntiparasitic activity. The association of the phenylpyrazole
pronil with the insect growth regulator, (S)-methoprene
s well known for its efﬁcacy against adult and immature
ea stages and for its ability to break the ﬂea life cycle on
reated animals and in their environment (Ritzhaupt et al.,
000; Young et al., 2004; Franc and Yao, 2007; Bonneau
t al., 2010; Cadiergues et al., 2011; Everett et al., 2011).
he objective of the studies presented in this paper was
o examine the efﬁcacy of Broadline® against adult and
mmature stages of several strains of C. felis ﬂeas. For this
ix controlled, blinded and randomized laboratory stud-
es were conducted in four different laboratories located
n Germany, South Africa, and the United States.
. Materials and methods
.1. Animals
All animals were healthy, purpose-bred laboratory short
air cats. Each study was conducted under a controlled
nd blinded design, with cats randomly allocated to two
roups (treated and control), each with eight (studies 1–5),
r six cats (Study 6). Before treatment, the good health
f each cat was conﬁrmed by a physical examination
onducted by a veterinarian, and by daily health obser-
ations by trained personnel. The protocol of the studies
as reviewed and approved by the Merial Institutionalology 202 (2014) 54–58 55
Animal Care and Use Committee. Cats were handled with
due regard for their welfare. To detect the presence or
absence of any treatment-related or unrelated health
abnormality or adverse event, health observations were
conducted at hourly intervals for four hours after treatment
and daily thereafter throughout all studies.
2.2. Study design
The studies were designed in accordance with the
“World Association for the Advancement of Veterinary
Parasitology (W.A.A.V.P.) guidelines for evaluating the
efﬁcacy of parasiticides for the treatment, prevention
and control of ﬂea and tick infestation on dogs and
cats” (Marchiondo et al., 2007), and were conducted in
accordance with Good Clinical Practices as described in
International Cooperation on Harmonisation of Techni-
cal Requirements for Registration of Veterinary Medicinal
Products (VICH) guideline GL9 (EMEA, 2000). All animals
were managed similarly, with due regard for their well-
being and in compliance with Merial Ethics Committee,
other local applicable regulations and requirements, and
International laws and ethics.
2.3. Flea strains
The six studies were conducted by four different inves-
tigators in four different laboratories. Each study used a
distinct ﬂea colony for infestations, sourced from North
America, Germany, or from Germany and South Africa. All
ﬂeas were laboratory-maintained C. felis.
2.4. Treatment
Cats assigned to the control groups were not treated.
On Study Day 0, each cat in the treated groups received
a topical application of BROADLINE® at the minimum
recommended dose of 0.12 mL/kg body weight (bw), deliv-
ering 10 mg/kg bw ﬁpronil, 12 mg/kg bw (S)-methoprene,
0.5 mg/kg bw eprinomectin and 10 mg/kg bw praziquantel.
The treatments were applied directly onto the skin, after
parting the hair, in one spot on the midline of the neck
between the base of the skull and the shoulder blades.
2.5. Flea infestations and adult ﬂea counts
Each cat was  infested with 100 (±5) unfed adult ﬂeas on
Days 2, 7, 14, 21 and 28. An additional ﬂea infestation was
performed on Day 35 for 2 studies. All live ﬂeas remaining
on the cats were removed and counted via thorough comb-
ing of all body areas with a ﬁne-tooth ﬂea comb on Day 1
at 24 h after treatment (72 h after pre-treatment infesta-
tion), and at 24 h after each of the subsequent weekly ﬂea
infestations.
2.6. Evaluation of the adult emergence from ﬂea eggsThe adult emergence after incubation of the ﬂea eggs
collected during the month after treatment was evalu-
ated in two  studies using the study design described by
Franc et al. (2007). Brieﬂy, each cat was  infested with
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Table 1
Efﬁcacy of BROADLINE against adult ﬂeas at 24 h after treatment or infestations.
Study and origin of the ﬂea strain Flea count time-point
Day 1 Day 8 Day 15 Day 22 Day 29 Day 36
Study 1 GeoMean control cats 83.0 81.8 85.3 84.3 89.7 90.5
Northern California, USA GeoMean treated cats 3.9 0.5 0.3 2.4 5.8 4.1
Efﬁcacy against Fleasa 95.3% 99.4% 99.6% 97.1% 93.5% 95.4%
P  value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Study  2 GeoMean control cats 60.8 61.8 64.5 60.8 68.4 67.8
South Germany GeoMean treated cats 1.8 0.0 0.0 0.0 0.6 2.4
Efﬁcacy against ﬂeas 97.0% 100% 100% 100% 99.1% 96.4%
P  value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Study  3 GeoMean control cats 56.5 73.1 73.9 68.9 71.5 ND
Central California, USA GeoMean treated cats 6.4 0 0 0 1.7 ND
Efﬁcacy against ﬂeas 88.7% 100% 100% 100% 97.6% ND
P  value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Study  4 GeoMean control cats 74.4 67.0 62.3 62.3 72.9 ND
Germany mixed with
South Africa
GeoMean treated cats 3.0 0.0 0.2 0.0 0.0 ND
Efﬁcacy against ﬂeas 96.0% 100% 99.7% 100% 100% ND
P  value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
red to coCombined percent efﬁcacy at 24 h 94.3% 
a Efﬁcacy = percent reduction of live adult ﬂea counts in treated compa
ND: not done.
100 (±5) gravid ﬂeas that had previously fed and matured
for two days on untreated donor cats. This was  done to
ensure that the ﬂeas used for infestation produced eggs
immediately after being placed on the cats and prior to
being incapacitated or killed by the ﬁpronil component of
the combination product, to allow for evaluation of (S)-
methoprene ovicidal and larvicidal activity. Each cat was
infested on Days 1, 7, 14, 21, 28 and 35. The ﬂea eggs pro-
duced on each cat were collected for two days after each
infestation and incubated in Petri dishes containing sand
and nutritive medium at 21.0–29.5 ◦C and 61.4–86.1% rel-
ative humidity. After ﬁve weeks of incubation, all emerged
adult ﬂeas were killed via freezing and counted, pupae were
dissected and any normal encased adults were included in
the counts.
2.7. Data analysis
For the evaluation of efﬁcacy against adult ﬂeas, the
ﬂea counts were transformed to the natural logarithm of
(count +1) for calculation of geometric means for each
treatment group. The percent efﬁcacy was calculated as
100 × [(C − T)/C], where C is the geometric mean of the ﬂea
counts among the untreated cats and T is the geometric
mean among the treated cats. The log counts of the treated
groups among were compared to the log counts of the
untreated groups using an F-test adjusted for the alloca-
tion blocks used to randomize the cats to treatment group.
The mixed procedure in SAS® version 9.1.3 was  used for
the analysis, with the treatment groups listed as a ﬁxed
effect and the allocation blocks listed as a random effect. All
testing was two-sided at the signiﬁcance level of P = 0.05.
For the evaluation of efﬁcacy against adult emergence
(studies 5 and 6), the rate of adult ﬂea emergence was
assessed as the mean number of adult ﬂeas emerged (after
ﬁve weeks of egg incubation) divided by the mean number
of eggs collected and incubated at each time point for each99.9% 99.8% 99.3% 97.6% 95.9%
ntrol cats.
cat. Arithmetic means were used because the emergence
of an adult ﬂea from an incubated ﬂea egg is a binomial
response. At each time point, the percent reduction of
adult emergence from the eggs collected from the treated
compared to the control cats was calculated as
100 × [1 − T/C], where T and C are the proportion of
emerged adults compared to the number of eggs collected
for the treated and control groups respectively. The results
were analyzed as a repeated ANOVA using the GLIMMIX
procedure in SAS. Time point was  the repeated measure
and cat-within-treatment group was  the subject. For this
analysis, the treatment, time point, and treatment-by-time
point interaction were listed as the ﬁxed effects, while
allocation blocks were listed as the only random effects.
3. Results
3.1. Flea counts
The adult ﬂea counts throughout the studies in the
treated and untreated groups are summarized in Table 1.
In all studies, the geometric means of the ﬂea counts of
untreated cats ranged from 56.5 to 90. As the design of
the studies was similar, a percent efﬁcacy combining the
results of the 4 studies was  calculated. At each time point in
all studies, the number of live ﬂeas was  signiﬁcantly lower
on treated animals versus control (P < 0.001). At 24 h after
treatment the pooled percent curative efﬁcacy was 94.3%.
The preventive efﬁcacy was  above 99% for the 3 following
weeks and it was  still at 95.9% 5 weeks after treatment.
3.2. Adult emergenceThe numbers, proportions and percent reduction of
adult ﬂea emergence are presented in Table 2. In the two
egg hatch inhibition studies, a sufﬁcient number of eggs
were obtained from control and treated animals (minimum
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Table  2
Percent reduction of adult emergence from eggs produced on cats treated with BROADLINE.
Study and origin of the
ﬂea strain
Egg collection
weeka
Proportion of emerged adult ﬂeasb Percent reduction of adult
ﬂea emergencec
P value
Control cats Cats treated with
BROADLINE
Study 5
North Germany
1 0.573 (57.3/100) 0.000 (0/75.7) 100.0 <.001
2  0.641 (64.1/100) 0.000 (0/33) 100.0 <.001
3  0.643 (64.3/100) 0.000 (0/40.7) 100.0 <.001
4  0.636 (63.6/100) 0.006 (0.3/50.7) 99.1 <.001
5  0.679 (67.9/100) 0.003 (0.3/77.1) 99.5 <.001
6  0.629 (62.9/100) 0.043 (4.3/100) 93.2 <.001
Study  6
North Carolina,
USA
1 0.682 (68.2/100) 0.000 (0/45.4) 100.0 <.001
2  0.755 (75.5/100) 0.012 (0.2/16.2) 98.4 <.001
3  0.605 (60.5/100) 0.010 (0.2/16) 98.3 <.001
4  0.632 (63.2/100) 0.000 (0/59.5) 100.0 <.001
5  0.558 (55.8/100) 0.011 (0.8/77.3) 98.1 <.001
6  0.388 (38.8/100) 0.018 (1.5/83.3) 95.4 <.001
a Eggs collected for 2 days after weekly infestation of each cat with ∼100 C. felis previously matured on untreated donor cats for 48 h.
b Proportion of emerged adult ﬂeas = arithmetic mean of the number of emerged adults/arithmetic mean of the number of eggs collected and incubated
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c Percent reduction = 100 × [1 − T/C], where T and C are the proportion 
ontrol groups, respectively
6 eggs collected) to demonstrate a signiﬁcantly lower
dult emergence in treated than control animals at each
ime point in weeks 1–6 (P < 0.001). After each weekly
nfestation, the efﬁcacy of Broadline against adult emer-
ence from incubated ﬂea eggs was greater than 98%
hrough week 5 and greater than 93% in week 6 in both
tudies.
. Discussion
As natural variation in the susceptibility of ﬂea strains
o insecticide compounds has been described (Rust, 2005),
he efﬁcacy of the novel topical combination was  tested
gainst 6 strains of ﬂeas of various origins including Africa,
urope and North America. The results illustrate the overall
igh level of efﬁcacy of Broadline against these ﬂeas strains,
ith slight variations in the natural susceptibility of ﬂeas
o this new product.
The results of studies 1–4 demonstrate the efﬁcacy
f the new formulation against adult ﬂeas, as previously
eported for ﬁpronil based products used on cats or dogs
Ritzhaupt et al., 2000; Franc and Yao, 2007; Franc and
eugnet, 2008; Bonneau et al., 2010; Boushira et al., 2011;
adiergues et al., 2011). The results of studies 5 and 6 con-
rm the inhibition of egg hatching, as published previously
or the combination of ﬁpronil and (S)-methoprene (Young
t al., 2004).
The association of ﬁpronil and (S)-methoprene with
prinomectin and praziquantel in the Broadline formula-
ion offers a wide spectrum of efﬁcacy against the main
arasites of cats including ecto- and endoparasites. The
ontrol of multiple concurrent parasitic infestations by a
ange of cat parasites is important for animal and pub-
ic health. Decisions on the need for such treatments will
e determined by the practicing veterinarian, based on
iagnosis and risk assessment according to the region and
he cat’s environment. The use of an integrated approach
or cats presenting multiple parasitic infestations, orged adults compared to the number of eggs collected for the treated and
presenting risks of such infestation, this new combination
product will be a distinct advantage. Its safety and efﬁcacy
as a combination spot-on product has been demonstrated
here and its ease of application may  improve owner com-
pliance.
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